Cerus Corporation (NASDAQ:CERS) Just Reported And Analysts Have Been Cutting Their Estimates

NasdaqGM:CERS 1 Year Share Price vs Fair Value
NasdaqGM:CERS 1 Year Share Price vs Fair Value
Explore Cerus's Fair Values from the Community and select yours

Last week, you might have seen that Cerus Corporation (NASDAQ:CERS) released its second-quarter result to the market. The early response was not positive, with shares down 3.1% to US$1.24 in the past week. The statutory results were mixed overall, with revenues of US$52m in line with analyst forecasts, but losses of US$0.03 per share, some 9.1% larger than the analysts were predicting. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

earnings-and-revenue-growth
NasdaqGM:CERS Earnings and Revenue Growth August 8th 2025

After the latest results, the three analysts covering Cerus are now predicting revenues of US$200.0m in 2025. If met, this would reflect a satisfactory 3.9% improvement in revenue compared to the last 12 months. Losses are expected to hold steady at around US$0.10. Before this latest report, the consensus had been expecting revenues of US$212.1m and US$0.10 per share in losses. So there seems to have been a moderate uplift in analyst sentiment with the latest consensus release, given the upgrade to loss per share forecasts for this year.

View our latest analysis for Cerus

The consensus price target was broadly unchanged at US$4.67, implying that the business is performing roughly in line with expectations, despite adjustments to both revenue and earnings estimates. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. Currently, the most bullish analyst values Cerus at US$5.00 per share, while the most bearish prices it at US$4.00. With such a narrow range of valuations, the analysts apparently share similar views on what they think the business is worth.

Of course, another way to look at these forecasts is to place them into context against the industry itself. We would highlight that Cerus' revenue growth is expected to slow, with the forecast 7.9% annualised growth rate until the end of 2025 being well below the historical 15% p.a. growth over the last five years. Juxtapose this against the other companies in the industry with analyst coverage, which are forecast to grow their revenues (in aggregate) 8.3% annually. So it's pretty clear that, while Cerus' revenue growth is expected to slow, it's expected to grow roughly in line with the industry.

Advertisement

The Bottom Line

The most obvious conclusion is that the analysts made no changes to their forecasts for a loss next year. They also downgraded their revenue estimates, although as we saw earlier, forecast growth is only expected to be about the same as the wider industry. Still, earnings per share are more important to value creation for shareholders. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that in mind, we wouldn't be too quick to come to a conclusion on Cerus. Long-term earnings power is much more important than next year's profits. We have forecasts for Cerus going out to 2027, and you can see them free on our platform here.

You should always think about risks though. Case in point, we've spotted 1 warning sign for Cerus you should be aware of.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGM:CERS

Cerus

Operates as a biomedical products company.

Excellent balance sheet with moderate growth potential.

Similar Companies

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7061.6% undervalued
6 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17036.6% undervalued
27 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
FU
ONTO logo
FundamentalFlow on Onto Innovation ·

Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Fair Value:US$38026.3% undervalued
19 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7448.8% undervalued
47 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative

Updated Narratives

WE
EPAM logo
Westimnster on EPAM Systems ·

Expect EPAM's fair value to reach 59.38

Fair Value:US$113.3814.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28023.3% undervalued
89 users have followed this narrative
9 users have commented on this narrative
0 users have liked this narrative
OS
oscargarcia
AVGO logo
oscargarcia on Broadcom ·

A tech powerhouse quietly powering the world’s AI infrastructure.

Fair Value:US$65026.3% undervalued
44 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8589.7% undervalued
124 users have followed this narrative
2 users have commented on this narrative
36 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9722.1% undervalued
56 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1930.3% undervalued
46 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative